Skip to main content

Advertisement

SpringerLink
Log in

Cardiovascular Genetic Medicine: Evolving Concepts, Rationale, and Implementation

  • Published:
Journal of Cardiovascular Translational Research Aims and scope Submit manuscript

Abstract

Cardiovascular genetic medicine is devoted to the identification and understanding of cardiac conditions resulting from genetic and genomic mechanisms and to the development and validation of diagnostic and treatment algorithms and guidelines. Cardiovascular genetic medicine clinics now provide expert cardiovascular subspecialty care, genetic counseling and clinical genetic testing, and will eventually provide disease-specific gene or genetic therapies. Currently, the most tractable diagnoses for cardiovascular genetic medicine are the single-gene disorders: the cardiomyopathies, the channelopathies, and others. The recent explosion of genetic knowledge within the single-gene disorders and consequent rapid proliferation of genetic testing enables far greater numbers of individuals to directly benefit from this progress. A compelling rationale exists for this approach: cardiovascular single-gene diseases commonly present with life-threatening events (e.g., sudden cardiac death, heart failure, stroke, etc.), but identification, evaluation, and treatment of individuals with presymptomatic genetic risk has the promise to prevent or ameliorate cardiovascular morbidity and mortality. Cardiovascular genetic medicine programs also anchor training and research, thereby enabling the next generation of academic specialists in cardiovascular genetic medicine to continue to improve cardiovascular health.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Robin, N.H., Tabereaux, P.B., Benza, R., & Korf, B.R. (2007). Genetic testing in cardiovascular disease. Journal of the American College of Cardiology, 50, 727–737.

    Article  PubMed  CAS  Google Scholar 

  2. Pollex, R.L., & Hegele, R.A. (2007). Copy number variation in the human genome and its implications for cardiovascular disease. Circulation, 115, 3130–3138.

    Article  PubMed  Google Scholar 

  3. Latronico, M.V., Catalucci, D., & Condorelli, G. (2007). Emerging role of microRNAs in cardiovascular biology. Circulation Research, 101, 1225–1236.

    Article  PubMed  CAS  Google Scholar 

  4. Gluckman, P.D., Hanson, M.A., & Beedle, A.S. (2007). Non-genomic transgenerational inheritance of disease risk. Bioessays, 29, 145–154.

    Article  PubMed  CAS  Google Scholar 

  5. Burkett, E.L., & Hershberger, R.E. (2005). Clinical and genetic issues in familial dilated cardiomyopathy. Journal of the American College of Cardiology, 45, 969–81.

    Article  PubMed  CAS  Google Scholar 

  6. Morita, H., Seidman, J., & Seidman, C.E. (2005). Genetic causes of human heart failure. Journal of Clinical Investigation, 115, 518–526.

    PubMed  CAS  Google Scholar 

  7. Taylor, M.R., Carniel, E., & Mestroni, L. (2004). Familial hypertrophic cardiomyopathy: Clinical features, molecular genetics and molecular genetic testing. Expert Review of Molecular Diagnostics, 4, 99–113.

    Article  PubMed  CAS  Google Scholar 

  8. Elliott, P., & McKenna, W.J. (2004). Hypertrophic cardiomyopathy. Lancet, 363, 1881–1891.

    Article  PubMed  CAS  Google Scholar 

  9. Nishimura, R.A., & Holmes Jr., D.R. (2004). Clinical practice. Hypertrophic obstructive cardiomyopathy. New England Journal of Medicine, 350, 1320–1327.

    Article  PubMed  CAS  Google Scholar 

  10. Ho, C.Y., & Seidman, C.E. (2006). A contemporary approach to hypertrophic cardiomyopathy. Circulation, 113, e858–e862.

    Article  PubMed  Google Scholar 

  11. Bos, J.M., Poley, R.N., Ny, M., Tester, D.J., Xu, X., Vatta, M., et al. (2006). Genotype–phenotype relationships involving hypertrophic cardiomyopathy-associated mutations in titin, muscle LIM protein, and telethonin. Molecular Genetics and Metabolism, 88, 78–85.

    Article  PubMed  CAS  Google Scholar 

  12. Kubo, T., Gimeno, J.R., Bahl, A., Steffensen, U., Steffensen, M., Osman, E., et al. (2007). Prevalence, clinical significance, and genetic basis of hypertrophic cardiomyopathy with restrictive phenotype. Journal of the American College of Cardiology, 49, 2419–2426.

    Article  PubMed  CAS  Google Scholar 

  13. Marian, A.J. (2007). Phenotypic plasticity of sarcomeric protein mutations. Journal of the American College of Cardiology, 49, 2427–2429.

    Article  PubMed  CAS  Google Scholar 

  14. Hoedemaekers, Y.M., Caliskan, K., Majoor-Krakauer, D., van de Laar, I., Michels, M., Witsenburg, M., et al. (2007). Cardiac beta-myosin heavy chain defects in two families with non-compaction cardiomyopathy: Linking non-compaction to hypertrophic, restrictive, and dilated cardiomyopathies. European Heart Journal, 28, 2732–2737.

    Article  PubMed  CAS  Google Scholar 

  15. Morimoto, S. (2008). Sarcomeric proteins and inherited cardiomyopathies. Cardiovascular Research, 77, 659–666.

    Article  PubMed  CAS  Google Scholar 

  16. Sen-Chowdhry, S., Syrris, P., & McKenna, W.J. (2007). Role of genetic analysis in the management of patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. Journal of the American College of Cardiology, 50, 1813–1821.

    Article  PubMed  CAS  Google Scholar 

  17. Moric-Janiszewska, E., & Markiewicz-Loskot, G. (2007). Review on the genetics of arrhythmogenic right ventricular dysplasia. Europace, 9, 259–266.

    Article  PubMed  Google Scholar 

  18. Roberts, R. (2006). Genomics and cardiac arrhythmias. Journal of the American College of Cardiology, 47, 9–21.

    Article  PubMed  CAS  Google Scholar 

  19. Priori, S.G., & Napolitano, C. (2006). Role of genetic analyses in cardiology: Part I: Mendelian diseases: Cardiac channelopathies. Circulation, 113, 1130–1135.

    Article  PubMed  Google Scholar 

  20. Lehnart, S.E., Ackerman, M.J., Benson Jr., D.W., Brugada, R., Clancy, C.E., Donahue, J.K., et al. (2007). Inherited arrhythmias: A National Heart, Lung, and Blood Institute and Office of Rare Diseases workshop consensus report about the diagnosis, phenotyping, molecular mechanisms, and therapeutic approaches for primary cardiomyopathies of gene mutations affecting ion channel function. Circulation, 116, 2325–2345.

    Article  PubMed  CAS  Google Scholar 

  21. Robinson, P.N., Arteaga-Solis, E., Baldock, C., Collod-Beroud, G., Booms, P., De Paepe, A., et al. (2006). The molecular genetics of Marfan syndrome and related disorders. Journal of Medical Genetics, 43, 769–787.

    Article  PubMed  CAS  Google Scholar 

  22. Mizuguchi, T., & Matsumoto, N. (2007). Recent progress in genetics of Marfan syndrome and Marfan-associated disorders. Journal of Human Genetics, 52, 1–12.

    Article  PubMed  CAS  Google Scholar 

  23. Chan, S.Y., & Loscalzo, J. (2008). Pathogenic mechanisms of pulmonary arterial hypertension. Journal of Molecular and Cellular Cardiology, 44, 14–30.

    Article  PubMed  CAS  Google Scholar 

  24. Newman, J.H., Phillips 3rd, J.A., & Loyd, J.E. (2008). Narrative review: The enigma of pulmonary arterial hypertension: New insights from genetic studies. Annals of Internal Medicine, 148, 278–283.

    PubMed  Google Scholar 

  25. Hegele, R.A. (2006). Genetic susceptibility to heart disease in Canada: Lessons from patients with familial hypercholesterolemia. Genome, 49, 1343–1350.

    Article  PubMed  Google Scholar 

  26. Soutar, A.K., & Naoumova, R.P. (2007). Mechanisms of disease: Genetic causes of familial hypercholesterolemia. Nature Clinical Practice Cardiovascular Medicine, 4, 214–225.

    Article  PubMed  CAS  Google Scholar 

  27. Arnett, D.K., Baird, A.E., Barkley, R.A., Basson, C.T., Boerwinkle, E., Ganesh, S.K., et al. (2007). Relevance of genetics and genomics for prevention and treatment of cardiovascular disease: A scientific statement from the American Heart Association Council on Epidemiology and Prevention, the Stroke Council, and the Functional Genomics and Translational Biology Interdisciplinary Working Group. Circulation, 115, 2878–901.

    Article  PubMed  Google Scholar 

  28. Fatkin, D. (2007). Guidelines for the diagnosis and management of familial dilated cardiomyopathy. Heart, Lung and Circulation, 16, 19–21.

    Article  PubMed  Google Scholar 

  29. Semsarian, C. (2007). Guidelines for the diagnosis and management of hypertrophic cardiomyopathy. Heart, Lung and Circulation, 16, 16–18.

    Article  PubMed  Google Scholar 

  30. Cowan, J., Morales, A., Dagua, J., & Hershberger, R.E. (2008). Genetic testing and genetic counseling in cardiovascular genetic medicine: Overview and preliminary recommendations. Congestive Heart Failure, 14, 105–113.

    Article  Google Scholar 

  31. Morales, A., Cowan, J., Dagua, J., & Hershberger, R.E. (2008). Family history: An essential tool for cardiovascular genetic medicine. Congestive Heart Failure, 14, 37–45.

    Article  PubMed  Google Scholar 

  32. Van Driest, S.L., Ommen, S.R., Tajik, A.J., Gersh, B.J., & Ackerman, M.J. (2005). Yield of genetic testing in hypertrophic cardiomyopathy. Mayo Clinic Proceedings, 80, 739–744.

    Article  PubMed  Google Scholar 

  33. Richard, P., Charron, P., Carrier, L., Ledeuil, C., Cheav, T., Pichereau, C., et al. (2003). Hypertrophic cardiomyopathy: Distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy. Circulation, 107, 2227–2232.

    Article  PubMed  Google Scholar 

  34. Maron, B.J., McKenna, W.J., Danielson, G.K., Kappenberger, L.J., Kuhn, H.J., Seidman, C.E., et al. (2003). American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. Journal of the American College of Cardiology, 42, 1687–1713.

    Article  PubMed  Google Scholar 

  35. Charron, P., Heron, D., Gargiulo, M., Richard, P., Dubourg, O., Desnos, M., et al. (2002). Genetic testing and genetic counselling in hypertrophic cardiomyopathy: The French experience. Journal of Medical Genetics, 39, 741–746.

    Article  PubMed  CAS  Google Scholar 

  36. Michels, M., Hoedemaekers, Y.M., Kofflard, M.J., Frohn-Mulder, I., Dooijes, D., Majoor-Krakauer, D., et al. (2007). Familial screening and genetic counselling in hypertrophic cardiomyopathy: The Rotterdam experience. Netherlands Heart Journal, 15, 184–190.

    CAS  PubMed  Google Scholar 

  37. van Langen, I.M., Hofman, N., Tan, H.L., & Wilde, A.A. (2004). Family and population strategies for screening and counselling of inherited cardiac arrhythmias. Annals of Medicine, 36(Suppl 1), 116–124.

    Article  PubMed  Google Scholar 

  38. Skinner, J.R. (2007). Guidelines for the diagnosis and management of familial long QT syndrome. Heart, Lung and Circulation, 16, 22–24.

    Article  PubMed  Google Scholar 

  39. Hendriks, K.S., Grosfeld, F.J., van Tintelen, J.P., van Langen, I.M., Wilde, A.A., van den Bout, J., et al. (2005). Can parents adjust to the idea that their child is at risk for a sudden death?: Psychological impact of risk for long QT syndrome. American Journal of Medical Genetics, 138, 107–112.

    Google Scholar 

  40. van Langen, I.M., Birnie, E., Schuurman, E., Tan, H.L., Hofman, N., Bonsel, G.J., et al. (2005). Preferences of cardiologists and clinical geneticists for the future organization of genetic care in hypertrophic cardiomyopathy: A survey. Clinical Genetics, 68, 360–368.

    Article  PubMed  Google Scholar 

  41. Keating, M.T., & Sanguinetti, M.C. (2001). Molecular and cellular mechanisms of cardiac arrhythmias. Cell, 104, 569–580.

    Article  PubMed  CAS  Google Scholar 

  42. Ingles, J., Doolan, A., Chiu, C., Seidman, J., Seidman, C., & Semsarian, C. (2005). Compound and double mutations in patients with hypertrophic cardiomyopathy: Implications for genetic testing and counselling. Journal of Medical Genetics, 42, e59.

    Article  PubMed  CAS  Google Scholar 

  43. Westenskow, P., Splawski, I., Timothy, K.W., Keating, M.T., & Sanguinetti, M.C. (2004). Compound mutations: A common cause of severe long-QT syndrome. Circulation, 109, 1834–1841.

    Article  PubMed  Google Scholar 

  44. Schwartz, P.J., Priori, S.G., & Napolitano, C. (2003). How really rare are rare diseases?: The intriguing case of independent compound mutations in the long QT syndrome. Journal of Cardiovascular Electrophysiology, 14, 1120–1121.

    Article  PubMed  Google Scholar 

  45. Van Driest, S.L., Vasile, V.C., Ommen, S.R., Will, M.L., Tajik, A.J., Gersh, B.J., et al. (2004). Myosin binding protein C mutations and compound heterozygosity in hypertrophic cardiomyopathy. Journal of the American College of Cardiology, 44, 1903–1910.

    Article  PubMed  CAS  Google Scholar 

  46. Parks, S., Kushner, J.D., Nauman, D., Burgess, D., Ludwigsen, S., Peterson, A., et al. (2008). Lamin A/C mutation analysis in a cohort of 324 unrelated patients with idiopathic or idiopathic dilated cardiomyopathy. American Heart Journal, in press.

  47. Hershberger, R., Parks, S., Kushner, J.D., Li, D., Ludwigsen, S., Jakobs, P., et al. (2008). Coding sequence mutations identified in MYH7, TNNT2, SCN5A, CSRP3, LBD3, and TCAP from 313 patients with familial or idiopathic dilated cardiomyopathy. Clinical and Translational Science, in press.

  48. Nussbaum, R. L., McInnes, R. R., & Willard, H. F. (2004). Thompson & Thompson genetics in medicine, revised reprint edition (6th ed.). Philadelphia, PA: Saunders.

    Google Scholar 

  49. GeneReviews at GeneTests: Medical genetics information resource. GeneTests/GeneClinics. Retrieved March 17, 2008, from http://www.genetests.org.

  50. Manning, N., Kaufman, L., & Roberts, P. (2005). Genetics of cardiological disorders. Seminars in Fetal and Neonatal Medicine, 10, 259–269.

    Article  PubMed  Google Scholar 

  51. Harper, P.S. (2004). Practical genetic counseling (6th ed.). London: Oxford University Press.

    Google Scholar 

  52. OMIMÔ—Online Mendelian Inheritance in Man. Retrieved March 17, 2008, from http://www.ncbi.nlm.nih.gov/omim/.

  53. Allanson, J.E. (2008). Noonan syndrome. In: GeneReviews at GeneTests: Medical genetics information resource. GeneTests/GeneClinics 2007. Retrieved March 17, 2008, from http://www.genetests.org.

  54. Dietz, H.C. (2008). Marfan syndrome. In: GeneReviews at GeneTests: Medical genetics information resource. GeneTests/GeneClinics 2005. Retrieved March 17, 2008, from http://www.genetests.org.

  55. Hejtmancik, J.F., Brink, P.A., Towbin, J., Hill, R., Brink, L., Tapscott, T., et al. (1991). Localization of gene for familial hypertrophic cardiomyopathy to chromosome 14q1 in a diverse US population. Circulation, 83, 1592–1597.

    PubMed  CAS  Google Scholar 

  56. Wimalasundera, R.C., & Gardiner, H.M. (2004). Congenital heart disease and aneuploidy. Prenatal Diagnosis, 24, 1116–1122.

    Article  PubMed  CAS  Google Scholar 

  57. Rimoin, D.L., Connor, M.J., Pyeritz, R.E., Korf, B.R., eds. (2007). Emery and Rimoin’s principles and practice of medical genetics (5th ed., vol. 1). Philadelphia, PA: Elsevier.

  58. Pajkrt, E., Weisz, B., Firth, H.V., & Chitty, L.S. (2004). Fetal cardiac anomalies and genetic syndromes. Prenatal Diagnosis, 24, 1104–1115.

    Article  PubMed  CAS  Google Scholar 

  59. Ho, K.K.L., Anderson, K.M., Kannel, W.B., Grossman, W., & Levy, D. (1993). Survival after the onset of congestive heart failure in Framingham heart study subjects. Circulation, 88, 107–115.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Cardiovascular Division, Clinical Research Building, Miller School of Medicine, University of Miami, P.O. Box 019132 (C-205), Miami, FL, 33101, USA

    Ray E. Hershberger

Authors
  1. Ray E. Hershberger
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ray E. Hershberger.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hershberger, R.E. Cardiovascular Genetic Medicine: Evolving Concepts, Rationale, and Implementation. J. of Cardiovasc. Trans. Res. 1, 137–143 (2008). https://doi.org/10.1007/s12265-008-9031-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12265-008-9031-3

Keywords

Search

Navigation